FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and lose weight. The company is hopingContinue Reading
TUESDAY, April 15, 2025 (HealthDay News) — Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury. The company said the injury went away after the person stopped taking the drug, called danuglipron, The Associated PressContinue Reading
MONDAY, April 7, 2025 (HealthDay News) — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications. Catherine Howden, a spokeswoman for the Centers for Medicare and Medicaid ServicesContinue Reading
WEDNESDAY, April 2, 2025 (HealthDay News) — The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform. The company said Tuesday it now provides access to Zepbound, a brand-name version of the drug tirzepatide, as well as to generic liraglutide. ZepboundContinue Reading
TUESDAY, April 1, 2025 (HealthDay News) — Fasting every other day can prompt more weight loss than simply cutting calories, a new clinical trial shows. People who undertook 4:3 intermittent fasting lost just under 8% of their body weight within a year, compared to a 5% loss among people whoContinue Reading
FRIDAY, March 28, 2025 (HealthDay News) — Splenda doesn’t directly add calories to your diet, but the sweetener still might lead people to pack on pounds, a new study says. The sugar substitute might spur on a person’s appetite and feelings of hunger, potentially leading them to overeat, according toContinue Reading
THURSDAY, March 27, 2025 (HealthDay News) — A mom’s health and lifestyle choices can affect her kids’ risk of obesity as adults, a new study says. Specifically, a child is 3 to 4 times more likely to become an obese adult if their mom was obese, researchers reported March 26Continue Reading
WEDNESDAY, March 26, 2025 (HealthDay News) — Chafing, blisters and sores are common problems for people fitted with an artificial limb. The artificial limb’s fixed, rigid shape can’t adapt to changes in a person’s body, ultimately causing it to rub against a person’s residual limb. “Ultimately, no matter how sophisticatedContinue Reading
TUESDAY, March 25, 2025 (HealthDay News) — Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed by United Bio-Technology (Hengqin) Co.,Continue Reading
MONDAY, March 24, 2025 (HealthDay News) — People dealing with heart disease, diabetes or obesity are behind the eight ball when it comes to their chances of living longer. But they can improve their odds if they start following a healthy plant-based diet, according to a study scheduled for presentationContinue Reading
WEDNESDAY, March 12, 2025 (HealthDay News) — Purposeful splishing and splashing can help you trim your waist size and drop excess pounds, a new evidence review has concluded. Water aerobics led to about 6 pounds of weight loss and more than an inch off the waists of overweight and obeseContinue Reading
FRIDAY, March 7, 2025 (HealthDay News) — The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, announced Wednesday that it has lowered its monthly cost by 23%.Continue Reading
TUESDAY, March 4, 2025 (HealthDay News) — More than half of adults and a third of children and teens worldwide will be overweight or obese by 2050, a comprehensive global analysis has concluded. Overweight and obesity rates in adults, children and teens more than doubled over the past three decades,Continue Reading
FRIDAY, Feb. 28, 2025 (HealthDay News) — GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has concluded. Earlier research had potentially linked these drugs — which are used to treat type 2 diabetes and obesity — with suicidal thoughts and self-harm,Continue Reading